Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
04 2019
Historique:
received: 08 11 2018
accepted: 29 03 2019
revised: 25 04 2019
pubmed: 16 4 2019
medline: 9 5 2019
entrez: 16 4 2019
Statut: epublish

Résumé

Klebsiella pneumoniae has emerged as an important cause of two distinct public health threats: multi-drug resistant (MDR) healthcare-associated infections and drug susceptible community-acquired invasive infections. These pathotypes are generally associated with two distinct subsets of K. pneumoniae lineages or 'clones' that are distinguished by the presence of acquired resistance genes and several key virulence loci. Genomic evolutionary analyses of the most notorious MDR and invasive community-associated ('hypervirulent') clones indicate differences in terms of chromosomal recombination dynamics and capsule polysaccharide diversity, but it remains unclear if these differences represent generalised trends. Here we leverage a collection of >2200 K. pneumoniae genomes to identify 28 common clones (n ≥ 10 genomes each), and perform the first genomic evolutionary comparison. Eight MDR and 6 hypervirulent clones were identified on the basis of acquired resistance and virulence gene prevalence. Chromosomal recombination, surface polysaccharide locus diversity, pan-genome, plasmid and phage dynamics were characterised and compared. The data showed that MDR clones were highly diverse, with frequent chromosomal recombination generating extensive surface polysaccharide locus diversity. Additional pan-genome diversity was driven by frequent acquisition/loss of both plasmids and phage. In contrast, chromosomal recombination was rare in the hypervirulent clones, which also showed a significant reduction in pan-genome diversity, largely driven by a reduction in plasmid diversity. Hence the data indicate that hypervirulent clones may be subject to some sort of constraint for horizontal gene transfer that does not apply to the MDR clones. Our findings are relevant for understanding the risk of emergence of individual K. pneumoniae strains carrying both virulence and acquired resistance genes, which have been increasingly reported and cause highly virulent infections that are extremely difficult to treat. Specifically, our data indicate that MDR clones pose the greatest risk, because they are more likely to acquire virulence genes than hypervirulent clones are to acquire resistance genes.

Identifiants

pubmed: 30986243
doi: 10.1371/journal.pgen.1008114
pii: PGENETICS-D-18-02153
pmc: PMC6483277
doi:

Substances chimiques

Lipopolysaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008114

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 1993 Aug;61(8):3164-74
pubmed: 8335346
Infect Immun. 2014 Jun;82(6):2356-67
pubmed: 24664504
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Mol Biol Evol. 2016 Nov;33(11):2860-2873
pubmed: 27501945
Clin Infect Dis. 2018 Jul 2;67(2):161-170
pubmed: 29340588
Infect Immun. 2002 May;70(5):2583-90
pubmed: 11953399
BMC Res Notes. 2015 Aug 04;8:332
pubmed: 26238567
Int J Infect Dis. 2015 Aug;37:107-12
pubmed: 26141415
PLoS One. 2015 Mar 04;10(3):e0116516
pubmed: 25738592
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5099-100
pubmed: 27270278
Mol Microbiol. 1994 Sep;13(6):939-53
pubmed: 7854127
Genome Med. 2014 Nov 20;6(11):90
pubmed: 25422674
Bioinformatics. 2009 Aug 1;25(15):1968-9
pubmed: 19497936
PeerJ. 2015 May 28;3:e985
pubmed: 26038737
Nat Ecol Evol. 2017 Sep;1(9):1354-1363
pubmed: 29046540
Genome Med. 2018 Oct 29;10(1):77
pubmed: 30371343
Plasmid. 2017 May;91:42-52
pubmed: 28286183
Antimicrob Agents Chemother. 2014 Dec;58(12):7347-57
pubmed: 25267672
BMC Bioinformatics. 2007 Jun 18;8:209
pubmed: 17577412
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
J Antimicrob Chemother. 2017 Nov 01;72(11):3025-3034
pubmed: 28961793
PLoS One. 2014 May 22;9(5):e96292
pubmed: 24852749
FEMS Microbiol Rev. 2017 May 1;41(3):252-275
pubmed: 28521338
Genome Biol Evol. 2015 Apr 10;7(5):1267-79
pubmed: 25861820
J Infect Dis. 2014 Dec 1;210(11):1734-44
pubmed: 25001459
J Antimicrob Chemother. 2013 Oct;68(10):2234-44
pubmed: 23722448
PLoS One. 2018 Feb 22;13(2):e0191958
pubmed: 29470491
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4988-93
pubmed: 24639510
Antimicrob Agents Chemother. 2015 Jul;59(7):3966-72
pubmed: 25896708
Front Microbiol. 2018 Jun 05;9:1197
pubmed: 29951041
mBio. 2014 Jun 24;5(3):e01355-14
pubmed: 24961694
Biotechnol Lett. 2018 Apr;40(4):679-687
pubmed: 29429073
Lancet Infect Dis. 2018 Jan;18(1):23-24
pubmed: 29102520
Infect Immun. 1995 Mar;63(3):847-52
pubmed: 7868255
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
Genome Med. 2017 Jan 24;9(1):6
pubmed: 28118859
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
FEMS Microbiol Rev. 2004 Feb;28(1):79-100
pubmed: 14975531
Sci Rep. 2015 Oct 23;5:15573
pubmed: 26493302
PLoS Comput Biol. 2014 Apr 10;10(4):e1003537
pubmed: 24722319
Microb Genom. 2018 Sep;4(9):
pubmed: 29985125
Front Cell Infect Microbiol. 2018 Jan 22;8:4
pubmed: 29404282
Infect Immun. 2011 Aug;79(8):3309-16
pubmed: 21576334
Virulence. 2018 Dec 31;9(1):838-844
pubmed: 29683780
BMC Genomics. 2009 Feb 09;10:71
pubmed: 19203375
Trends Microbiol. 2014 Dec;22(12):686-96
pubmed: 25304194
J Antimicrob Chemother. 2019 May 1;74(5):1218-1222
pubmed: 30770708
Proc Natl Acad Sci U S A. 2016 May 17;113(20):5658-63
pubmed: 27140615
Virology. 1981 Aug;113(1):363-78
pubmed: 7269247
Front Cell Infect Microbiol. 2017 Mar 31;7:103
pubmed: 28409125
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3574-81
pubmed: 26100894
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
mBio. 2016 Jun 28;7(3):
pubmed: 27353756
mBio. 2016 Sep 13;7(5):
pubmed: 27624128
PLoS One. 2013;8(2):e56847
pubmed: 23457627
PLoS One. 2008;3(11):e3817
pubmed: 19043570
Curr Opin Microbiol. 2008 Oct;11(5):472-7
pubmed: 19086349
Nature. 2017 Feb 9;542(7640):237-241
pubmed: 28005056
Int J Med Microbiol. 2017 Oct;307(7):422-429
pubmed: 28789913
Sci Rep. 2016 Jul 13;6:29316
pubmed: 27406977
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2005 Aug 15;21(16):3422-3
pubmed: 15976072
J Infect Dis. 2008 Jun 15;197(12):1717-27
pubmed: 18433330
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29618504
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Microb Genom. 2017 Aug 18;3(10):e000128
pubmed: 29177087
Microb Genom. 2017 Sep 14;3(10):e000132
pubmed: 29177090
Emerg Infect Dis. 2014 Nov;20(11):1812-20
pubmed: 25341126
Bioinformatics. 2008 Jun 1;24(11):1403-5
pubmed: 18397895
Trends Microbiol. 2016 Dec;24(12):944-956
pubmed: 27742466
Emerg Infect Dis. 2016 Sep;22(9):1687-8
pubmed: 27532217
J Bacteriol. 2010 Jun;192(12):3144-58
pubmed: 20382770
Nat Rev Microbiol. 2009 Nov;7(11):828-36
pubmed: 19834481
Clin Infect Dis. 2015 Sep 15;61(6):892-9
pubmed: 26206847
Lancet Infect Dis. 2018 Jan;18(1):37-46
pubmed: 28864030
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
mBio. 2017 Feb 21;8(1):
pubmed: 28223459
Microbiol Spectr. 2014;2(5):1-15
pubmed: 25705573
Nucleic Acids Res. 2016 Jun 2;44(10):4539-50
pubmed: 27130947
Curr Opin Microbiol. 2018 Oct;45:131-139
pubmed: 29723841
PLoS One. 2009;4(3):e4982
pubmed: 19319196
Genome Biol Evol. 2019 Nov 1;11(11):3240-3251
pubmed: 31665331
mBio. 2015 Jul 21;6(4):e00630
pubmed: 26199326
Curr Opin Infect Dis. 2018 Aug;31(4):341-346
pubmed: 29847328
J Med Microbiol. 2018 Jan;67(1):118-128
pubmed: 29205138
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Microbiology (Reading). 2011 Dec;157(Pt 12):3446-3457
pubmed: 21964731
PLoS One. 2015 Jul 21;10(7):e0133727
pubmed: 26196384
Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78
pubmed: 27067320
EMBO Mol Med. 2015 Feb 20;7(3):227-39
pubmed: 25712531
Trends Microbiol. 2018 Dec;26(12):1008-1021
pubmed: 30037568
mBio. 2018 Apr 24;9(2):
pubmed: 29691332
Nat Genet. 2014 Mar;46(3):305-309
pubmed: 24509479
Nat Commun. 2018 Jul 13;9(1):2703
pubmed: 30006589
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Lancet Infect Dis. 2018 Jan;18(1):2-3
pubmed: 28864028
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Microb Genom. 2016 Dec 12;2(12):e000102
pubmed: 28348840
J Basic Microbiol. 2017 Apr;57(4):325-336
pubmed: 28156004
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Kelly L Wyres (KL)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Ryan R Wick (RR)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Louise M Judd (LM)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Roni Froumine (R)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Alex Tokolyi (A)

Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Claire L Gorrie (CL)

Department of Infectious Diseases and Microbiology Unit, The Alfred Hospital, Melbourne, Victoria, Australia.

Margaret M C Lam (MMC)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.

Sebastián Duchêne (S)

Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Adam Jenney (A)

Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Kathryn E Holt (KE)

Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH